Office of the Chief Medical Officer
The Johnson & Johnson Office of the Chief Medical Officer (OCMO) champions healthcare innovation that patients can trust. We believe health is everything, uniquely combining safety science, epidemiology bioethics and lifecycle management expertise to inform evidence- and science-based product decisions that put patients first. We lead with care and rigorous science to build a world where patients are as safe as possible and people-centered innovation is paramount.
Johnson & Johnson Chief Medical Officer
Penny Heaton, M.D., is the Global Head of the Johnson & Johnson Office of the Chief Medical Officer which, aligned with Our Credo, keeps patients at the center of the company’s efforts to tackle the world’s toughest health challenges through its leadership in Medical Safety, Epidemiology, Bioethics and product Lifecycle Management.
Delivering medical safety excellence that puts people first
Safety is embedded in our culture and aligned with Our Credo. We enable proactive medical safety excellence across the product lifecycle, so our medicines and devices are safe and effective for patients.
-
-
-
Safety science innovation: Putting patients first
Steve Lin and Richard Mayer, leaders in Johnson & Johnson’s Office of the Chief Medical Officer, share insights into the company’s patient-centered approach. -
-
Decisions through real-world evidence
We are leading the way in generating regulatory-grade real-world evidence (RWE) to further our understanding of the safety and effectiveness of our products and inform more timely product decisions.
-
-
What is real-world evidence and how does it help patients?
As Johnson & Johnson’s Vice President and Global Head of Epidemiology, Josh Gagne and his team study real-world data to further understand the safety and effectiveness of our products across many different kinds of patients and clinical environments to help inform important decisions that ultimately improve care for patients -
Ethical scientific practices & policies
We provide bioethical guidance to teams across our enterprise to help drive innovation that is respectful to the rights and welfare of all people.